As prescribed studies highlighted the critical role of GRP78 in PC development, the current investigation was made to study whether the anticancer impact of sFLT01 chimeric receptor could be mediated through suppressing the VEGF/GRP78 axis. The gene discussed is HSPA5; the disease is pachyonychia congenita.